Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-04-09 2:17 pm Purchase | 2021-03-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FEDERATED HERMES INC. FHI | 1,950,000 10.160% | 714,967 (+57.89%) | Filing History |
| 2021-02-12 3:06 pm Purchase | 2020-12-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | FEDERATED HERMES INC. FHI | 1,235,033 6.340% | 1,235,033 (New Position) | Filing History |
| 2020-12-10 1:14 pm Purchase | 2020-11-30 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | T. Rowe Price Associates, Inc. | 3,639,190 2.800% | 2,124 (+0.06%) | Filing History |
| 2020-11-10 3:09 pm Purchase | 2020-10-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE | T. Rowe Price Associates, Inc. | 3,637,066 18.700% | 3,637,066 (New Position) | Filing History |
| 2020-11-06 4:10 pm Purchase | 2020-10-27 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 21.500% | 27,349,211 (New Position) | Filing History |
| 2020-11-04 4:45 pm Purchase | 2020-10-27 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | BC Perception Holdings LP | 60,300,063 47.400% | 60,300,063 (New Position) | Filing History |